ネオアジュバント免疫化学療法後の局所的に進行した胃がんにおける凝固マーカーの予測値
Arunkumar Krishnan1,2, Diptasree Mukherjee3
1Department of Medicine, Wake Forest University School of Medicine, Winston-Salem, NC 27103, United States.
World journal of gastrointestinal oncology
|August 21, 2025
まとめ
高血圧は, neoadjuvant immunochemotherapy (NICT) を受けている局所的に進行した胃がん (LAGC) 患者の予後バイオマーカーとして有望である. より大きな多センター研究でこれらの発見を検証するには,さらなる研究が必要です.
科学分野:
- 腫瘍学
- 血液学
- バイオマーカーの発見
背景:
- 胃がん (GC) は,世界的な健康上の大きな課題です.
- 非侵襲的なバイオマーカーは 癌の診断と治療の改善に不可欠です
- 癌の予後指標として高血圧が浮上しています
研究 の 目的:
- 局所的に進行した胃がん (LAGC) の患者における高血栓の予後値の評価.
- 現在の研究の限界を特定し,将来の方向性を提案する.
- 凝固マーカーの統合を他の臨床データとリスクの階層化について検討する.
主な方法:
- 高血圧とLAGCに関する既存の研究のレビュー
- 制限の分析は,遡及的な設計,単一センターのフォーカス,および小さなサンプルサイズを含む.
- 将来の多センター試験と機械学習の統合の必要性を議論する.
主要な成果:
- 新補助免疫化学療法 (NICT) の後のLAGC患者における予後バイオマーカーとして,高血栓が潜在的であることを示した.
- 既存の研究は,遡及的設計,単一センターデータ,および小さなサンプルサイズによって制限されています.
- 手術前併発症や全身性炎症は 混同因子としてさらなる調査が必要である.
結論:
- 予見的な多センター試験は,予後的なバイオマーカーとして高血栓を検証するために不可欠です.
- 機械学習アルゴリズムは,凝固マーカーと臨床変数を統合することで,リスクの分層化を高めることができます.
- ライフスタイルの介入と高度なイメージングを含む多学科アプローチは,GC患者の成果を改善するために不可欠です.
関連する概念動画
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.